Insider · CIK 0001365619

Brege Laura

Reports to the SEC for 10 companies · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001365619

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-15	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,772 sh	—	—	3,772
2026-06-15	MIRMMirum Pharmaceuticals, Inc. · Deferred Stock UnitsA Award	Director	AAward	+1,980 sh	—	—	1,980
2026-06-10	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.9K sh	—	—	10,891
2026-06-10	PCRXPacira BioSciences, Inc.A Award	Director	AAward	+6,405 sh	—	—	30,120
2026-06-05	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.4K sh	—	—	16,377
2026-05-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+8,107 sh	—	—	23,202
2026-05-29	ACADACADIA PHARMACEUTICALS INC · Director Stock Options (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,004
2026-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,107 sh	—	—	0
2026-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director	AAward	+9,311 sh	—	—	9,311
2025-09-11	MIRMMirum Pharmaceuticals, Inc.S Sale	Director	SSale	−1,491 sh	$75.07	−$112K	15,703
2025-09-11	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−17K sh	—	—	0
2025-09-11	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+17K sh	$15.00	+$255K	32,703
2025-09-11	MIRMMirum Pharmaceuticals, Inc.S Sale	Director	SSale	−15.5K sh	$74.34	−$1.15M	17,194
2025-06-16	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-06-11	PCRXPacira BioSciences, Inc.A Award	Director	AAward	+6,163 sh	—	—	23,715
2025-06-11	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.3K sh	—	—	11,279
2025-06-04	ACADACADIA PHARMACEUTICALS INCS Sale	Director	SSale	−14.4K sh	$21.78	−$315K	15,095
2025-05-29	ACADACADIA PHARMACEUTICALS INC · Director Stock Options (Right to Buy)A Award	Director	AAward	+13.8K sh	—	—	13,793
2025-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−9,387 sh	—	—	0
2025-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director	AAward	+8,107 sh	—	—	8,107
2025-05-29	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,703 sh	—	—	15,703
2025-05-29	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,268 sh	—	—	6,268
2025-05-29	MIRMMirum Pharmaceuticals, Inc. · Deferred Stock UnitsA Award	Director	AAward	+3,977 sh	—	—	3,977
2025-05-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+9,387 sh	—	—	29,541
2025-05-29	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,703 sh	—	—	0
2024-08-16	PCRXPacira BioSciences, Inc.P Purchase	Director	PPurchase	+1,000 sh	$12.81	+$12.8K	17,552
2024-06-12	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.2K sh	—	—	12,179
2024-06-12	PCRXPacira BioSciences, Inc.A Award	Director	AAward	+5,230 sh	—	—	16,552
2024-06-10	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.6K sh	—	—	20,594
2024-06-05	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+5,703 sh	—	—	5,703
2024-06-05	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,779 sh	—	—	8,779
2024-05-29	ACADACADIA PHARMACEUTICALS INC · Director Stock Options (Right to Buy)A Award	Director	AAward	+16K sh	—	—	15,959
2024-05-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+6,652 sh	—	—	20,154
2024-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,652 sh	—	—	0
2024-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director	AAward	+9,387 sh	—	—	9,387
2023-06-14	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.9K sh	—	—	12,925
2023-06-14	PCRXPacira BioSciences, Inc.A Award	Director	AAward	+1,775 sh	—	—	11,322
2023-06-12	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17K sh	—	—	17,000
2023-06-12	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.1K sh	—	—	22,123
2023-06-12	ACADACADIA PHARMACEUTICALS INCS Sale	Director	SSale	−4,500 sh	$24.87	−$112K	13,502
2023-06-05	PCRXPacira BioSciences, Inc.S Sale	Director	SSale	−600 sh	$38.74	−$23.2K	9,547
2023-06-01	ACADACADIA PHARMACEUTICALS INC · Director Stock Options (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,045
2023-06-01	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+8,552 sh	—	—	18,002
2023-06-01	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,552 sh	—	—	0
2023-06-01	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director	AAward	+6,652 sh	—	—	6,652
2023-04-03	PCRXPacira BioSciences, Inc.S Sale	Director	SSale	−7,000 sh	$40.72	−$285K	10,147
2023-04-03	PCRXPacira BioSciences, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,000 sh	$29.90	+$209K	17,147
2023-04-03	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,000 sh	—	—	0
2023-01-12	ACADACADIA PHARMACEUTICALS INCS Sale	Director	SSale	−12.5K sh	$18.25	−$228K	0
2023-01-12	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+12.5K sh	$17.01	+$213K	12,500

Recent filings

Accepted (ET)
Jun 174
Brege Laura0001365619-26-000005
SEC(opens sec.gov)
Jun 174
Brege Laura0001365619-26-000004
SEC(opens sec.gov)
Jun 124
Brege Laura0001628280-26-043002
SEC(opens sec.gov)
Jun 14
Brege Laura0001365619-26-000002
SEC(opens sec.gov)
Sep 124
Brege Laura0001415889-25-024463
SEC(opens sec.gov)
Jun 184
Brege Laura0001562180-25-004961
SEC(opens sec.gov)
Jun 134
Brege Laura0001396814-25-000080
SEC(opens sec.gov)
Jun 54
Brege Laura0001415889-25-015832
SEC(opens sec.gov)
Jun 24
Brege Laura0001415889-25-015303
SEC(opens sec.gov)

Companies

Address

C/O MIRUM PHARMACEUTICALS, INC. 989 E HILLSDALE BLVD., SUITE 300

FOSTER CITY, CA, 94404